Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 27 studies | 32% ± 12% | |
fibroblast | 25 studies | 24% ± 8% | |
macrophage | 24 studies | 28% ± 12% | |
classical monocyte | 22 studies | 29% ± 14% | |
non-classical monocyte | 17 studies | 35% ± 17% | |
smooth muscle cell | 16 studies | 21% ± 6% | |
astrocyte | 15 studies | 30% ± 12% | |
oligodendrocyte | 14 studies | 42% ± 14% | |
monocyte | 12 studies | 33% ± 12% | |
pericyte | 11 studies | 24% ± 8% | |
myeloid cell | 11 studies | 31% ± 14% | |
endothelial cell of lymphatic vessel | 10 studies | 25% ± 10% | |
glutamatergic neuron | 10 studies | 46% ± 24% | |
microglial cell | 10 studies | 30% ± 9% | |
oligodendrocyte precursor cell | 10 studies | 32% ± 11% | |
B cell | 9 studies | 25% ± 5% | |
GABAergic neuron | 9 studies | 41% ± 23% | |
epithelial cell | 9 studies | 42% ± 19% | |
adipocyte | 9 studies | 24% ± 8% | |
dendritic cell | 9 studies | 33% ± 17% | |
conventional dendritic cell | 8 studies | 29% ± 15% | |
neuron | 8 studies | 42% ± 19% | |
basal cell | 8 studies | 32% ± 18% | |
interneuron | 7 studies | 41% ± 20% | |
mononuclear phagocyte | 6 studies | 27% ± 8% | |
myofibroblast cell | 6 studies | 26% ± 10% | |
neutrophil | 6 studies | 21% ± 4% | |
ciliated cell | 6 studies | 32% ± 12% | |
club cell | 6 studies | 22% ± 5% | |
retina horizontal cell | 6 studies | 26% ± 6% | |
Mueller cell | 6 studies | 25% ± 5% | |
endothelial cell of vascular tree | 6 studies | 23% ± 11% | |
type I pneumocyte | 6 studies | 21% ± 6% | |
natural killer cell | 5 studies | 20% ± 4% | |
naive B cell | 5 studies | 21% ± 5% | |
hematopoietic precursor cell | 5 studies | 31% ± 13% | |
endothelial cell of artery | 5 studies | 17% ± 3% | |
vein endothelial cell | 5 studies | 24% ± 12% | |
retinal ganglion cell | 5 studies | 27% ± 9% | |
capillary endothelial cell | 5 studies | 19% ± 4% | |
cardiac muscle cell | 5 studies | 36% ± 10% | |
lymphocyte | 5 studies | 27% ± 5% | |
type II pneumocyte | 5 studies | 22% ± 5% | |
connective tissue cell | 5 studies | 26% ± 9% | |
mast cell | 5 studies | 25% ± 9% | |
alveolar macrophage | 5 studies | 32% ± 17% | |
squamous epithelial cell | 4 studies | 42% ± 18% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 22% ± 5% | |
abnormal cell | 4 studies | 29% ± 16% | |
retinal bipolar neuron | 4 studies | 19% ± 2% | |
granule cell | 4 studies | 26% ± 7% | |
amacrine cell | 4 studies | 24% ± 5% | |
retinal pigment epithelial cell | 4 studies | 30% ± 16% | |
hepatocyte | 4 studies | 48% ± 18% | |
enteroendocrine cell | 4 studies | 25% ± 7% | |
goblet cell | 4 studies | 32% ± 15% | |
leukocyte | 4 studies | 27% ± 4% | |
pancreatic A cell | 3 studies | 31% ± 14% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 19% ± 4% | |
neural crest cell | 3 studies | 16% ± 1% | |
GABAergic interneuron | 3 studies | 28% ± 3% | |
glial cell | 3 studies | 27% ± 7% | |
progenitor cell | 3 studies | 22% ± 4% | |
brush cell | 3 studies | 35% ± 5% | |
GABAergic amacrine cell | 3 studies | 22% ± 1% | |
OFF-bipolar cell | 3 studies | 18% ± 2% | |
rod bipolar cell | 3 studies | 21% ± 3% | |
regulatory T cell | 3 studies | 17% ± 1% | |
mesothelial cell | 3 studies | 24% ± 6% | |
muscle cell | 3 studies | 37% ± 19% | |
neural progenitor cell | 3 studies | 30% ± 5% | |
ependymal cell | 3 studies | 35% ± 12% | |
hematopoietic stem cell | 3 studies | 37% ± 14% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 46% ± 8% | |
intestinal crypt stem cell | 3 studies | 19% ± 1% | |
respiratory goblet cell | 3 studies | 23% ± 5% | |
T cell | 3 studies | 18% ± 2% | |
transit amplifying cell | 3 studies | 36% ± 27% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 38% ± 19% | |
lung | 9 studies | 27% ± 11% | |
eye | 7 studies | 25% ± 13% | |
peripheral blood | 5 studies | 32% ± 11% | |
heart | 5 studies | 26% ± 8% | |
liver | 4 studies | 32% ± 15% | |
intestine | 4 studies | 25% ± 8% | |
pancreas | 3 studies | 30% ± 17% | |
adipose | 3 studies | 25% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 5500.84 | 966 / 966 | 100% | 76.28 | 527 / 527 |
kidney | 100% | 4008.83 | 89 / 89 | 100% | 58.59 | 901 / 901 |
liver | 100% | 3326.93 | 226 / 226 | 100% | 54.59 | 406 / 406 |
ovary | 100% | 5877.03 | 180 / 180 | 100% | 81.18 | 430 / 430 |
pancreas | 100% | 5976.25 | 328 / 328 | 100% | 73.82 | 178 / 178 |
prostate | 100% | 4535.38 | 245 / 245 | 100% | 85.02 | 502 / 502 |
stomach | 100% | 3643.98 | 359 / 359 | 100% | 74.62 | 286 / 286 |
uterus | 100% | 5835.64 | 170 / 170 | 100% | 81.03 | 459 / 459 |
breast | 100% | 5778.98 | 459 / 459 | 100% | 93.42 | 1117 / 1118 |
brain | 100% | 4090.62 | 2639 / 2642 | 100% | 87.88 | 705 / 705 |
thymus | 100% | 4077.96 | 653 / 653 | 100% | 71.76 | 604 / 605 |
lung | 100% | 5790.38 | 577 / 578 | 100% | 74.01 | 1154 / 1155 |
skin | 100% | 6556.83 | 1808 / 1809 | 100% | 67.54 | 471 / 472 |
bladder | 100% | 5496.43 | 21 / 21 | 100% | 73.17 | 502 / 504 |
esophagus | 100% | 5346.11 | 1445 / 1445 | 99% | 74.10 | 182 / 183 |
adrenal gland | 100% | 4073.63 | 258 / 258 | 98% | 48.92 | 226 / 230 |
adipose | 100% | 6189.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5814.48 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 71.30 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 85.85 | 29 / 29 |
muscle | 100% | 7165.33 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4682.40 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 63.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 60.42 | 1 / 1 |
peripheral blood | 100% | 10676.94 | 928 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 4042.31 | 839 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | UBE2R2 |
Protein name | Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2) Alternative protein UBE2R2 |
Synonyms | UBC3B CDC34B |
Description | FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes monoubiquitination and 'Lys-48'-linked polyubiquitination. May be involved in degradation of katenin. . |
Accessions | Q712K3 ENST00000263228.4 L8ECH4 |